EVALUACION DE NUEVOS AGENTES PARA EL CANCER DE PANCREAS
Columnista Experta de SIIC T. R. Jeffry Evans
en colaboración con
Fecha de aprobación: 20 de septiembre, 2004
Primera edición en siicsalud:
1 de agosto, 2005
Sección Artículos originales,
subsección
Expertos de Iberoamérica,
página
/des/expertocompleto.php/70142
Especialidad principal:
Oncología
Especialidades relacionadas:
Farmacología,Gastroenterología,Medicina Farmacéutica,Medicina Interna,
MacKay HJ, Hoekstra R, Eskens FALM, Loos WJ, Crawford D, Voi M, Van Vreckem A, Evans TRJ, Verweij J. A phase I pharmacokinetic and pharmacodynamic study of the farnesyl transfesrase inhibitor BMS-214662 in combination with cisplatin in patients with advanced solid tumors, Clinical Cancer Research 10:2636-2644
Jodrell DI, Evans TRJ, Steward W, Cameron D, Prediville J, Aschele C, Noberasco C, Lind M, Carmichael J, Dobbs N, Camboni G, Gatti B, DeBraud F. Phase II studies with BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma, European Journal of Cancer 40:1872-1877
Bisland AE, Anderson C, Fletcher-Monaghan AJ, McGregor F, Evans TRJ, Ganly I, Knox RJ, Plumb JA, Keith WN. Selection ablation of human cancer cells by telomerase-specific adenoviral gene therapy vectors expressing bacterial nitorductase, Oncogene 22:370-380
Diaz-Rubio E, Evans TRJ, Tabernero J, Cassidy J, Sastre J, Eatock M, Bisset D, Regueiro P, Baselga J. Capecitabine (Xeloda) in combination with oxaliplatin: a phase 1, dose-escalation study in patients with advanced or metastatic solid tumors, Annals of Oncology 13:558-565
Evans TRJ, Colston KW, Lofts FJ, Cunningham D, Anthoney DA, Gogas H, DeBono JS, Hamberg KJ, Skov T, Mansi JL. A phase II trial of the vitamin D analogue Seocalcitol (EB 1089) in patients with inoperable pancreatic cancer, British Journal of Cancer 86:680-685
Evans TRJ, Pentheroudakis G, Paul J, McInnes A, Blackie R, Raby N, Morrison R, Fullarton GM, Soukop M, McDonald AC. Phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma, Annals of Oncology 13:1469-1478
DeBono JS, Dalgleish AG, Carmichael J, Diffley J, Lofts FJ, Fyffe D, Ellard S, Gordon RJ, Brindley CR, Evans TRJ. A phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide, Clinical Cancer Research 6:397-405
T. R. Jeffry Evans
